Jump to contentJump to search

Core competencies for postdoctoral fellows and young scientists

An academic career can have very diverse goals, which can be pursued individually depending on one's interests. To obtain a university professorship, both a strong interest in research and a passion for teaching are prerequisites for achieving this career goal. In addition to the professional requirements, the young scientists should also have additional key qualifications that support their everyday research work.

The Faculty attaches particular importance to the continuous training of young scientists and the qualified supervision of doctoral candidates. Applicants for admission to habilitation must provide evidence of at least four continuing education courses on core competencies for young scientists and university teachers. Participation in further training to ensure good scientific practice is mandatory.

Paediatric oncology at University Hospital Düsseldorf
US hyperthermia award goes to PD Dr. Rüdiger Wessalowski

Zoom

Photo: PD Dr. Rüdiger Wessalowski, University-Hospital Düsseldorf, Department of Paediatric Oncology, Haematology and Clinical Immunology

This Department in Düsseldorf is currently the only one in the world to also treat children with the targeted overheating of the tumour tissue in combination with chemotherapy and/or radiotherapy. Prof. Dr. Rolf Issels at the Medical Center of the University of Munich (LMU) and PD Dr. Rüdiger Wessalowski are the only German physicians so far to have won this highest distinction by the STM.

Within the framework of experimental and clinical research projects, Wessalowski has developed new treatment concepts for the use of hyperthermia in children in cases where standard therapies are unsuccessful or not sufficiently successful or whose illness returned after standard therapies. In 2013, Wessalowski received the ESHO BSD Award from the European Society for Hyperthermic Oncology. The keynote speech by the 30th recipient of the Robinson award as part of the symposium was entitled “Apoptosis or Necrosis – Mechanisms of Cell Death induced by Hyperthermia”.

 

Background:

How hyperthermia works

Hyperthermia is used to treat patients suffering from cancerous tumours that are not responding or not responding adequately to standard therapies as well as patients who relapse after standard therapies with chemotherapy as well as radiation. Hyperthermia with targeted overheating of the tumour tissue is used additionally. It increases the effectiveness of the two aforementioned therapies, and the thermal effect itself also destroys the tumour. Clinical application of hyperthermia in children was established around 25 years ago in Düsseldorf under the supervision of Prof. Dr. Ulrich Göbel, former Director of the Department of Paediatric Oncology, Haematology and Immunology.

 

J. Eugene Robinson Award

The J. Eugene Robinson Award is presented to acknowledge the work of J. Eugene Robinson, a US doctor who was a pioneer in hyperthermic research. The award is presented each year to researchers who have made outstanding contributions in this field. Robinson himself first used hyperthermia to treat cancerous tumours in the 1960s together with radiation and continued his investigations in various areas related to hyperthermia including thermal dose and time-temperature relationships. 

Autor/in:
Kategorie/n: Auch in Englisch, Forschungsnews Englisch

Paediatric oncology at University Hospital Düsseldorf
US hyperthermia award goes to PD Dr. Rüdiger Wessalowski

Zoom

Photo: PD Dr. Rüdiger Wessalowski, University-Hospital Düsseldorf, Department of Paediatric Oncology, Haematology and Clinical Immunology

This Department in Düsseldorf is currently the only one in the world to also treat children with the targeted overheating of the tumour tissue in combination with chemotherapy and/or radiotherapy. Prof. Dr. Rolf Issels at the Medical Center of the University of Munich (LMU) and PD Dr. Rüdiger Wessalowski are the only German physicians so far to have won this highest distinction by the STM.

Within the framework of experimental and clinical research projects, Wessalowski has developed new treatment concepts for the use of hyperthermia in children in cases where standard therapies are unsuccessful or not sufficiently successful or whose illness returned after standard therapies. In 2013, Wessalowski received the ESHO BSD Award from the European Society for Hyperthermic Oncology. The keynote speech by the 30th recipient of the Robinson award as part of the symposium was entitled “Apoptosis or Necrosis – Mechanisms of Cell Death induced by Hyperthermia”.

 

Background:

How hyperthermia works

Hyperthermia is used to treat patients suffering from cancerous tumours that are not responding or not responding adequately to standard therapies as well as patients who relapse after standard therapies with chemotherapy as well as radiation. Hyperthermia with targeted overheating of the tumour tissue is used additionally. It increases the effectiveness of the two aforementioned therapies, and the thermal effect itself also destroys the tumour. Clinical application of hyperthermia in children was established around 25 years ago in Düsseldorf under the supervision of Prof. Dr. Ulrich Göbel, former Director of the Department of Paediatric Oncology, Haematology and Immunology.

 

J. Eugene Robinson Award

The J. Eugene Robinson Award is presented to acknowledge the work of J. Eugene Robinson, a US doctor who was a pioneer in hyperthermic research. The award is presented each year to researchers who have made outstanding contributions in this field. Robinson himself first used hyperthermia to treat cancerous tumours in the 1960s together with radiation and continued his investigations in various areas related to hyperthermia including thermal dose and time-temperature relationships. 

Autor/in:
Kategorie/n: Auch in Englisch, Forschungsnews Englisch

Paediatric oncology at University Hospital Düsseldorf
US hyperthermia award goes to PD Dr. Rüdiger Wessalowski

Zoom

Photo: PD Dr. Rüdiger Wessalowski, University-Hospital Düsseldorf, Department of Paediatric Oncology, Haematology and Clinical Immunology

This Department in Düsseldorf is currently the only one in the world to also treat children with the targeted overheating of the tumour tissue in combination with chemotherapy and/or radiotherapy. Prof. Dr. Rolf Issels at the Medical Center of the University of Munich (LMU) and PD Dr. Rüdiger Wessalowski are the only German physicians so far to have won this highest distinction by the STM.

Within the framework of experimental and clinical research projects, Wessalowski has developed new treatment concepts for the use of hyperthermia in children in cases where standard therapies are unsuccessful or not sufficiently successful or whose illness returned after standard therapies. In 2013, Wessalowski received the ESHO BSD Award from the European Society for Hyperthermic Oncology. The keynote speech by the 30th recipient of the Robinson award as part of the symposium was entitled “Apoptosis or Necrosis – Mechanisms of Cell Death induced by Hyperthermia”.

 

Background:

How hyperthermia works

Hyperthermia is used to treat patients suffering from cancerous tumours that are not responding or not responding adequately to standard therapies as well as patients who relapse after standard therapies with chemotherapy as well as radiation. Hyperthermia with targeted overheating of the tumour tissue is used additionally. It increases the effectiveness of the two aforementioned therapies, and the thermal effect itself also destroys the tumour. Clinical application of hyperthermia in children was established around 25 years ago in Düsseldorf under the supervision of Prof. Dr. Ulrich Göbel, former Director of the Department of Paediatric Oncology, Haematology and Immunology.

 

J. Eugene Robinson Award

The J. Eugene Robinson Award is presented to acknowledge the work of J. Eugene Robinson, a US doctor who was a pioneer in hyperthermic research. The award is presented each year to researchers who have made outstanding contributions in this field. Robinson himself first used hyperthermia to treat cancerous tumours in the 1960s together with radiation and continued his investigations in various areas related to hyperthermia including thermal dose and time-temperature relationships. 

Autor/in:
Kategorie/n: Auch in Englisch, Forschungsnews Englisch

Paediatric oncology at University Hospital Düsseldorf
US hyperthermia award goes to PD Dr. Rüdiger Wessalowski

Zoom

Photo: PD Dr. Rüdiger Wessalowski, University-Hospital Düsseldorf, Department of Paediatric Oncology, Haematology and Clinical Immunology

This Department in Düsseldorf is currently the only one in the world to also treat children with the targeted overheating of the tumour tissue in combination with chemotherapy and/or radiotherapy. Prof. Dr. Rolf Issels at the Medical Center of the University of Munich (LMU) and PD Dr. Rüdiger Wessalowski are the only German physicians so far to have won this highest distinction by the STM.

Within the framework of experimental and clinical research projects, Wessalowski has developed new treatment concepts for the use of hyperthermia in children in cases where standard therapies are unsuccessful or not sufficiently successful or whose illness returned after standard therapies. In 2013, Wessalowski received the ESHO BSD Award from the European Society for Hyperthermic Oncology. The keynote speech by the 30th recipient of the Robinson award as part of the symposium was entitled “Apoptosis or Necrosis – Mechanisms of Cell Death induced by Hyperthermia”.

 

Background:

How hyperthermia works

Hyperthermia is used to treat patients suffering from cancerous tumours that are not responding or not responding adequately to standard therapies as well as patients who relapse after standard therapies with chemotherapy as well as radiation. Hyperthermia with targeted overheating of the tumour tissue is used additionally. It increases the effectiveness of the two aforementioned therapies, and the thermal effect itself also destroys the tumour. Clinical application of hyperthermia in children was established around 25 years ago in Düsseldorf under the supervision of Prof. Dr. Ulrich Göbel, former Director of the Department of Paediatric Oncology, Haematology and Immunology.

 

J. Eugene Robinson Award

The J. Eugene Robinson Award is presented to acknowledge the work of J. Eugene Robinson, a US doctor who was a pioneer in hyperthermic research. The award is presented each year to researchers who have made outstanding contributions in this field. Robinson himself first used hyperthermia to treat cancerous tumours in the 1960s together with radiation and continued his investigations in various areas related to hyperthermia including thermal dose and time-temperature relationships. 

Autor/in:
Kategorie/n: Auch in Englisch, Forschungsnews Englisch
Responsible for the content: